FTSE 100 Stocks Fall Amid U.S.-Iran Fears and AstraZeneca Trial Setback

The FTSE 100 index fell as concerns over rising tensions between the U.S. and Iran impacted market sentiment. AstraZeneca (AZN) faced pressure after its trial results did not meet expectations, contributing to a decline in its stock price. The uncertainty surrounding geopolitical events can lead to increased volatility in markets, as seen with the FTSE 100's reaction. This matters for ordinary investors as geopolitical tensions can create fluctuations in stock values and investment returns.